Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 95, Issue , 2015, Pages 398-406

  Kim, Yoo Chun ^a   Oh, Kyung Hee ^a   Edelhauser, Henry F ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eye; Microneedles; Ocular drug delivery; Particle formulation; Suprachoroidal space

Indexed keywords

CARBOXYMETHYLCELLULOSE; HYALURONIC ACID; METHYLCELLULOSE; MICROSPHERE; NANOPARTICLE; POLYMER;

ANIMAL TISSUE; ARTICLE; CHOROID; CILIARY BODY; CONTROLLED RELEASE FORMULATION; CORNEA LIMBUS; DRUG DISTRIBUTION; HYDROPHOBICITY; MACULAR DEGENERATION; MICRONEEDLE; MOLECULAR WEIGHT; NONHUMAN; OPHTHALMIC DRUG DELIVERY DEVICE; PARTICLE SIZE; POLYMERIZATION; QUANTITATIVE ANALYSIS; RABBIT; RETINA; RETINA DISEASE; SCLERA; SHEAR RATE; VISCOSITY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; MEDICINAL CHEMISTRY; METABOLISM; NEEDLE; PROCEDURES; TIME FACTOR;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHOROID; CILIARY BODY; DRUG DELIVERY SYSTEMS; HYALURONIC ACID; MICROSPHERES; NANOPARTICLES; NEEDLES; POLYMERS; RABBITS; SCLERA; TIME FACTORS;

EID: 84943821195     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.05.020     Document Type: Article

References (41)

1. Y.C. Kim, B. Chiang, X. Wu, and M.R. Prausnitz Ocular delivery of macromolecules J. Control. Release 190 2014 172 181
2. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery AAPS J. 12 2010 348 360
3. N. Kuno, and S. Fujii Recent advances in ocular drug delivery systems Polymers 3 2011 193 221
4. S. Csukas, P. Bhattacherjee, L. Rhodes, and C.A. Paterson Prostaglandin E2 binding site distribution and subtype classification in the rabbit iris-ciliary body Prostaglandins 44 1992 199 208
5. C.B. Toris, B.T. Gabelt, and P.L. Kaufman Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction Surv. Ophthalmol. 53 Suppl. 1 2008 S107 S120
6. S.B. Bressler Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration Ophthalmology 116 2009 S1 S7
7. K.G. Janoria, S. Gunda, S.H. Boddu, and A.K. Mitra Novel approaches to retinal drug delivery Expert Opin. Drug Deliv. 4 2007 371 388
8. I. Merck & Co., Timoptic® 0.25% and 0.5% (Timolol Maleate Ophthalmic Solution) [Packing Insert], Merck & Co., Inc., Whitehouse Station, NJ 08889, USA, 2005.
9. R. Bhatt, K.W. Whittaker, S. Appaswamy, A. Desai, A. Fitt, and S. Sandramouli Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population Eye 19 2005 392 395
10. A. Ozkiris, and K. Erkilic Complications of intravitreal injection of triamcinolone acetonide Can. J. Ophthalmol. 40 2005 63 68
11. J.B. Jonas, R. Degenring, U. Vossmerbauemer, and B. Kamppeter Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide Eur. J. Ophthalmol. 15 2005 462 464
12. T.W. Olsen, X. Feng, K. Wabner, S.R. Conston, D.H. Sierra, D.V. Folden, M.E. Smith, and J.D. Cameron Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment Am. J. Ophthalmol. 142 2006 777 787
13. S. Einmahl, M. Savoldelli, F. D'Hermies, C. Tabatabay, R. Gurny, and F. Behar-Cohen Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye Invest. Ophthalmol. Vis. Sci. 43 2002 1533 1539
14. J. Hou, Y. Tao, Y.R. Jiang, and K. Wang In vivo and in vitro study of suprachoroidal fibrin glue Jpn. J. Ophthalmol. 53 2009 640 647
15. S.H. Kim, C.J. Galban, R.J. Lutz, R.L. Dedrick, K.G. Csaky, M.J. Lizak, N.S. Wang, G. Tansey, and M.R. Robinson Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging Invest. Ophthalmol. Vis. Sci. 48 2007 808 814
16. T.W. Olsen, X. Feng, K. Wabner, K. Csaky, S. Pambuccian, and J.D. Cameron Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model Invest. Ophthalmol. Vis. Sci. 52 2011 4749 4756
17. B.C. Gilger, J.H. Salmon, D.A. Wilkie, L.P. Cruysberg, J. Kim, M. Hayat, H. Kim, S. Kim, P. Yuan, S.S. Lee, S.M. Harrington, P.R. Murray, H.F. Edelhauser, K.G. Csaky, and M.R. Robinson A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis Invest. Ophthalmol. Vis. Sci. 47 2006 2596 2605
18. S.R. Patel, A.S. Lin, H.F. Edelhauser, and M.R. Prausnitz Suprachoroidal drug delivery to the back of the eye using hollow microneedles Pharm. Res. 28 2011 166 176
19. S.R. Patel, D.E. Berezovsky, B.E. McCarey, V. Zarnitsyn, H.F. Edelhauser, and M.R. Prausnitz Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye Invest. Ophthalmol. Vis. Sci. 53 2012 4433 4441
20. Y.C. Kim, H.F. Edelhauser, and M.R. Prausnitz Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye Adv. Health. Mater. 3 2014 1272 1282
21. A.K. Patel, H.J. Zambarakji, D.G. Charteris, and P.M. Sullivan Suprachoroidal silicone oil: recognition and possible mechanisms Eye 20 2006 854 856
22. S.R. Patel, H.F. Edelhauser, and M.R. Prausnitz Targeted drug delivery to the eye enabled by microneedles U.B. Kompella, H.F. Edelhauser, Drug Product Development for the Back of the Eye 2011 Springer New York 331 360
23. G. Kogan, L. Soltes, R. Stern, and P. Gemeiner Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications Biotechnol. Lett. 29 2007 17 25
24. V.K. Dada, N. Sindhu, and M.S. Sachdev Postoperative intraocular-pressure changes with use of different viscoelastics Ophthalmic Surg. Las. 25 1994 540 544
25. F.H. Silver, J. Librizzi, and D. Benedetto Use of viscoelastic solutions in ophthalmology - a review of physical-properties and long-term effects J. Long-Term Eff. Med. 2 1992 49 66
26. K.L. Goa, and P. Benfield Hyaluronic-acid - a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound-healing Drugs 47 1994 536 566
27. S.J. Falcone, D.M. Palmeri, and R.A. Berg Rheological and cohesive properties of hyaluronic acid J. Biomed. Mater. Res. A 76A 2006 721 728
28. DisCoVisc (Ophthalmic Viscosurgical Device) Package Insert, in: I. Alcon Laboratories (Ed.), Alcon Laboratories Inc., 2006, 2011.
29. Y. Li, J. Rodrigues, and H. Tomas Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications Chem. Soc. Rev. 41 2012 2193 2221
30. D.Y. Ko, U.P. Shinde, B. Yeon, and B. Jeong Recent progress of in situ formed gels for biomedical applications Prog. Polym. Sci. 38 2013 672 701
31. P. Agarwal, and I.D. Rupenthal Injectable implants for the sustained release of protein and peptide drugs Drug Discov. Today 18 2013 337 349
32. S. Kempe, and K. Mader In situ forming implants - an attractive formulation principle for parenteral depot formulations J. Control. Release 161 2012 668 679
33. R.C. Rowe, P.J. Sheskey, W.G. Cook, and M.E. Fenton Handbook of Pharmaceutical Excipients seventh ed. 2012 APhA/Pharmaceutical Press London
34. M. Tetz, S. Rizzo, and A.J. Augustin Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results Ophthalmologica 227 2012 183 189
35. V. Morales-Canton, R.R. Vera, M. Widmann, S.R. Patel, B. Yerxa, Suprachoroidal microinjection of bevacizumab is well tolerated in human patients, in: ARVO, Seattle, WA, 2014.
36. Y.C. Kim, H.F. Edelhauser, and M.R. Prausnitz Targeted delivery of anti-glaucoma drugs to the supraciliary space using microneedles Invest. Ophthalmol. Vis. Sci. 55 2014 7387 7397
37. T. Yasukawa, and Y. Ogura Medical devices for the treatment of eye diseases Handb. Exp. Pharmacol. 2010 469 489
38. S.S. Lee, P. Hughes, A.D. Ross, and M.R. Robinson Biodegradable implants for sustained drug release in the eye Pharm. Res. 27 2010 2043 2053
39. A. Garcia, J. Tully, S. Das, T. Pegoraro, L. Trevino, B. Maynor, T. Navratil, B. Yerxa, Precisely engineered biodegradable drug delivery systems for the extended release of prostaglandin analogues in the anterior chamber, in: ARVO, Orlando, FL, 2014.
40. G.A. Peyman, S.A. Meffert, and M.D. Conway Vitreoretinal Surgical Techniques second ed. 2001 Martin Dunitz United Kingdom
41. J.G. Gross, W.R. Freeman, M.H. Goldbaum, and T.L. Mendez Useful adjuncts for vitreoretinal surgery Br. J. Ophthalmol. 73 1989 435 439